Please enable Javascript
Stefano Luminari, MD
Articles by Stefano Luminari, MD
Dr. Luminari Remarks on EU Approval of Odronextamab for DLBCL, Follicular Lymphoma
Stefano Luminari, MD
Aggressive B-Cell Lymphoma
|
October 3, 2024
The positive safety profile of this bispecific antibody makes it well-suited for combination with other treatments.
View More